Thrombosis, Bleeding, and the Promise of Factor XI(a) Inhibition

被引:2
|
作者
Andreotti, Felicita [1 ,2 ,4 ]
Massetti, Massimo [1 ,2 ]
Montalescot, Gilles [3 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Sci, Rome, Italy
[2] Catholic Univ Med Sch, Rome, Italy
[3] Sorbonne Univ, Hop Pitie Salpetriere AP HP, Inst Cardiol, ACT Study Grp,INSERM UMRS 116, Paris, France
[4] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Sci, Largo Gemelli 8, I-00168 Rome, Italy
关键词
asundexian; atrial fibrillation; bleeding; factor XI inhibitor; myocardial infarction; placebo; stroke; FACTOR XIA; PREVENTION; DISORDERS;
D O I
10.1016/j.jacc.2023.12.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:679 / 681
页数:3
相关论文
共 50 条
  • [31] Factor XI in Clinical Bleeding and Thrombotic Disorders.
    Seligsohn, Uri
    Salomon, Ophira
    BLOOD, 2010, 116 (21) : 1759 - 1760
  • [32] PREDICTORS OF BLEEDING IN FACTOR-XI DEFICIENT PATIENTS
    BRENNER, B
    LUPO, H
    LAOR, A
    ZIVELIN, A
    LANIR, N
    SELIGSOHN, U
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1441 - 1441
  • [33] Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
    Buller, Harry Roger
    Bethune, Claudette
    Bhanot, Sanjay
    Gailani, David
    Monia, Brett P.
    Raskob, Gary E.
    Segers, Annelise
    Verhamme, Peter
    Weitz, Jeffrey I.
    BLOOD, 2014, 124 (21)
  • [34] Factor XI Antisense Oligonucleotide for Venous Thrombosis REPLY
    Buller, Harry R.
    Gailani, David
    Weitz, Jeffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (17): : 1672 - 1672
  • [35] Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency
    O'Connell, N. M.
    Riddell, A. F.
    Pascoe, G.
    Perry, D. J.
    Lee, C. A.
    HAEMOPHILIA, 2008, 14 (04) : 775 - 781
  • [36] The use of factor XI concentrates (Hemoleven, LFB) in patients with congenital factor XI deficiency and a known bleeding tendency
    McDonald, V
    Geoffrey, SF
    Rangarajan, S
    Mitchell, M
    BLOOD, 2005, 106 (11) : 510A - 511A
  • [37] Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk
    Zhang, Hong
    Lowenberg, Ester C.
    Crosby, Jeffrey R.
    MacLeod, A. Robert
    Zhao, Chenguang
    Gao, Dacao
    Black, Chris
    Revenko, Alexey S.
    Meijers, Joost C. M.
    Stroes, Erik S.
    Levi, Marcel
    Monia, Brett P.
    BLOOD, 2010, 116 (22) : 4684 - 4692
  • [38] Factor XI: structure, function and therapeutic inhibition
    Ali, Ahmed E.
    Becker, Richard C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024,
  • [39] Low factor VIII levels are a risk factor for bleeding in patients with factor XI deficiency
    Weiss, HJ
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) : 181 - 182
  • [40] von Willebrand factor: at the crossroads of bleeding and thrombosis
    Denis, Cecile V.
    Lenting, Peter J.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (04) : 353 - 361